Kamat, Aparna A.

Publications

Sort by

Co-Author Network

selected publications

Non-16/18 high-risk HPV infection predicts disease persistence and progression in women with an initial interpretation of LSIL. Cancer cytopathology. 2015 Academic Article GET IT
Times cited: 13
Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2012 Academic Article GET IT
Times cited: 43
Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer. The Lancet. Oncology. 2011 Academic Article GET IT
Times cited: 84
Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer. Cancer biology & therapy. 2010 Academic Article GET IT
Times cited: 47
Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors. Gynecologic oncology. 2010 Academic Article GET IT
Times cited: 96
Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker. Cancer. 2010 Academic Article GET IT
Times cited: 126
Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. The Journal of clinical investigation. 2010 Academic Article GET IT
Times cited: 219
Bridging the gap between cytotoxic and biologic therapy with metronomic topotecan and pazopanib in ovarian cancer. Molecular cancer therapeutics. 2010 Academic Article GET IT
Times cited: 45
Frequent downregulation of miR-34 family in human ovarian cancers. Clinical cancer research : an official journal of the American Association for Cancer Research. 2010 Academic Article GET IT
Times cited: 266
Anti-angiogenic properties of metronomic topotecan in ovarian carcinoma. Cancer biology & therapy. 2009 Academic Article GET IT
Times cited: 41
EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer. Cancer. 2009 Academic Article GET IT
Times cited: 51
Functional significance of VEGFR-2 on ovarian cancer cells. International journal of cancer. 2009 Academic Article GET IT
Times cited: 112
Dicer, Drosha, and outcomes in patients with ovarian cancer. The New England journal of medicine. 2008 Academic Article GET IT
Times cited: 598
Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer. Neoplasia (New York, N.Y.). 2008 Academic Article GET IT
Times cited: 102
Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Academic Article GET IT
Times cited: 60
HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Academic Article GET IT
Times cited: 123
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. Journal of the National Cancer Institute. 2008 Academic Article GET IT
Times cited: 220
Clinical and biological significance of vascular endothelial growth factor in endometrial cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 156
Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma. Cancer research. 2007 Academic Article GET IT
Times cited: 184
Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer research. 2007 Academic Article GET IT
Times cited: 125
Antitumor and antivascular effects of AVE8062 in ovarian carcinoma. Cancer research. 2007 Academic Article GET IT
Times cited: 75
Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 75
Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 385
Relaxin promotes prostate cancer progression. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 92
Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma. Cancer research. 2007 Academic Article GET IT
Times cited: 172
EphA2 overexpression is associated with angiogenesis in ovarian cancer. Cancer. 2007 Academic Article GET IT
Times cited: 93
Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer. Cancer research. 2007 Academic Article GET IT
Times cited: 130
Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer. Cancer biology & therapy. 2006 Academic Article GET IT
Times cited: 94
Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer. Journal of the National Cancer Institute. 2006 Academic Article GET IT
Times cited: 111
Analysis of EphA2 expression and mutant p53 in ovarian carcinoma. Cancer biology & therapy. 2006 Academic Article GET IT
Times cited: 17
Circulating cell-free DNA: a novel biomarker for response to therapy in ovarian carcinoma. Cancer biology & therapy. 2006 Academic Article GET IT
Times cited: 105
Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinoma. Cancer research. 2006 Academic Article GET IT
Times cited: 74
Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR. Annals of the New York Academy of Sciences. 2006 Academic Article GET IT
Times cited: 55
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2006 Academic Article GET IT
Times cited: 291
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nature medicine. 2006 Academic Article GET IT
Times cited: 936
The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2006 Academic Article GET IT
Times cited: 162
The role of relaxin in endometrial cancer. Cancer biology & therapy. 2006 Academic Article GET IT
Times cited: 51
Stress hormone-mediated invasion of ovarian cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research. 2006 Academic Article GET IT
Times cited: 400
Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 64
The merits of vascular targeting for gynecologic malignancies. Current oncology reports. 2005 Review GET IT
Endocrine effects of relaxin overexpression in mice. Endocrinology. 2005 Academic Article GET IT
Times cited: 29
Genetic targeting of relaxin and insl3 signaling in mice. Annals of the New York Academy of Sciences. 2005 Academic Article GET IT
Times cited: 17
Protein expression profiling of endometriosis: validation of 2-mm tissue microarrays. Fertility and sterility. 2004 Academic Article GET IT
Times cited: 19
Genetic targeting of relaxin and insulin-like factor 3 receptors in mice. Endocrinology. 2004 Academic Article GET IT
Times cited: 119
Superiority of electrocautery over the suture method for achieving cervical cone bed hemostasis. Obstetrics and gynecology. 2003 Academic Article GET IT
Times cited: 11
Genetics of endometriosis. Obstetrics and gynecology clinics of North America. 2003 Review GET IT
Times cited: 73
Mutations of the GREAT gene cause cryptorchidism. Human molecular genetics. 2002 Academic Article GET IT
Times cited: 214
Cephalic vein cutdown for inserting indwelling subclavian vein catheters in gynecologic oncology patients. The West Virginia medical journal. 2002 Academic Article GET IT
Times cited: 5
Wound infection in gynecologic surgery. Infectious diseases in obstetrics and gynecology. 2000 Academic Article GET IT
Times cited: 36

more ...

less ...

Background

education and training

M.S., University of Texas 2006
M.B.,B.S., Maharashtra University of Health Sciences, Seth G.S. Medical College (India) 1994

Contact

full name

Aparna A. Kamat

VIVO Weill Cornell Medical College

Aparna A. Kamat Associate Professor of Clinical Obstetrics and Gynecology

Publications

selected publications

Background

education and training

Contact

full name